See more : Velo3D, Inc. (VLD-WT) Income Statement Analysis – Financial Results
Complete financial analysis of Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dawnrays Pharmaceutical (Holdings) Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Caribbean Investment Holdings Limited (CIHL.L) Income Statement Analysis – Financial Results
- Lux Health Tech Acquisition Corp. (LUXAW) Income Statement Analysis – Financial Results
- DSV A/S (DSDVF) Income Statement Analysis – Financial Results
- Baosheng Media Group Holdings Limited (BAOS) Income Statement Analysis – Financial Results
- KANCO TEA & INDUSTRIES LIMITED (KANCOTEA.BO) Income Statement Analysis – Financial Results
Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.dawnrays.com
About Dawnrays Pharmaceutical (Holdings) Limited
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.15B | 1.28B | 1.17B | 1.02B | 950.01M | 948.94M | 882.48M | 824.35M | 985.00M | 783.80M | 914.97M | 856.54M | 1.08B | 1.29B | 1.08B | 947.71M | 919.95M | 788.80M | 734.00M | 584.76M | 491.39M | 327.92M |
| Cost of Revenue | 509.63M | 511.00M | 489.79M | 478.72M | 427.25M | 353.91M | 320.93M | 312.87M | 415.61M | 323.88M | 511.73M | 532.14M | 718.29M | 910.53M | 754.06M | 691.05M | 680.44M | 604.79M | 518.77M | 392.08M | 285.49M | 155.62M |
| Gross Profit | 641.52M | 766.68M | 675.36M | 545.55M | 522.75M | 595.03M | 561.55M | 511.48M | 569.39M | 459.92M | 403.25M | 324.40M | 362.75M | 376.16M | 328.05M | 256.66M | 239.50M | 184.01M | 215.23M | 192.68M | 205.90M | 172.31M |
| Gross Profit Ratio | 55.73% | 60.01% | 57.96% | 53.26% | 55.03% | 62.70% | 63.63% | 62.05% | 57.81% | 58.68% | 44.07% | 37.87% | 33.56% | 29.23% | 30.32% | 27.08% | 26.03% | 23.33% | 29.32% | 32.95% | 41.90% | 52.54% |
| Research & Development | 90.81M | 79.48M | 67.03M | 60.03M | 56.09M | 46.35M | 35.65M | 26.73M | 32.56M | 31.39M | 34.56M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 113.21M | 122.06M | 117.41M | 109.22M | 97.09M | 82.14M | 81.45M | 63.58M | 73.90M | 59.97M | 60.57M | 53.07M | 55.78M | 48.88M | 47.58M | 43.80M | 41.12M | 36.40M | 38.60M | 34.38M | 26.10M | 10.64M |
| Selling & Marketing | 147.05M | 142.73M | 109.03M | 54.57M | 84.81M | 106.85M | 88.09M | 98.90M | 94.47M | 99.41M | 112.75M | 104.71M | 100.86M | 95.67M | 101.21M | 79.40M | 69.22M | 53.67M | 54.23M | 58.99M | 56.80M | 52.31M |
| SG&A | 260.26M | 264.79M | 226.44M | 163.80M | 181.90M | 190.04M | 170.58M | 163.52M | 169.41M | 160.42M | 174.36M | 157.78M | 156.64M | 144.56M | 148.78M | 123.19M | 110.34M | 90.07M | 92.83M | 93.36M | 82.89M | 62.95M |
| Other Expenses | 290.46M | 445.00K | 111.00K | 716.00K | -68.97M | -57.40M | -45.99M | -38.10M | -50.12M | -54.81M | -51.85M | -30.55M | 2.70M | 22.17M | 28.03M | 17.41M | 21.95M | 26.59M | 18.21M | 14.86M | 10.51M | 8.77M |
| Operating Expenses | 641.52M | 347.75M | 255.63M | 226.89M | 220.88M | 248.80M | 217.46M | 191.58M | 212.72M | 212.39M | 220.02M | 152.00M | 187.90M | 166.73M | 176.81M | 140.60M | 132.29M | 116.66M | 111.04M | 108.22M | 93.40M | 71.72M |
| Cost & Expenses | 762.65M | 858.76M | 745.42M | 705.60M | 648.13M | 602.71M | 538.40M | 504.45M | 628.34M | 536.27M | 731.75M | 684.14M | 906.20M | 1.08B | 930.86M | 831.65M | 812.73M | 721.45M | 629.81M | 500.30M | 378.89M | 227.33M |
| Interest Income | 25.93M | 19.48M | 19.59M | 12.63M | 12.22M | 31.55M | 21.62M | 13.40M | 20.53M | 11.36M | 5.74M | 4.81M | 3.80M | 2.31M | 477.00K | 936.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 989.00K | 371.00K | 641.00K | 4.83M | 5.31M | 1.15M | 13.00K | 157.00K | 1.52M | 2.80M | 3.60M | 3.83M | 2.16M | 549.00K | 395.00K | 343.00K | 0.00 | 0.00 | 0.00 | 0.00 | 484.00K | 0.00 |
| Depreciation & Amortization | 83.89M | 66.41M | 57.55M | 59.58M | 53.43M | 51.63M | 52.65M | 52.82M | 53.25M | 45.52M | 34.47M | 29.83M | 28.60M | 26.13M | 26.09M | 23.96M | 24.06M | 23.02M | 17.71M | 12.70M | 6.10M | 5.19M |
| EBITDA | 498.94M | 505.19M | 433.89M | 395.71M | 341.59M | 430.56M | 418.36M | 386.27M | 432.83M | 308.15M | 227.98M | 178.29M | 209.94M | 235.56M | 177.94M | 140.02M | 131.27M | 90.37M | 121.91M | 97.15M | 118.60M | 105.78M |
| EBITDA Ratio | 43.34% | 36.86% | 37.24% | 36.43% | 35.96% | 41.73% | 44.65% | 43.79% | 40.66% | 36.81% | 22.93% | 20.70% | 19.42% | 18.31% | 16.44% | 14.77% | 14.27% | 11.46% | 16.61% | 16.61% | 24.14% | 32.26% |
| Operating Income | 431.38M | 410.03M | 380.76M | 320.50M | 290.36M | 345.06M | 342.03M | 309.03M | 347.23M | 242.97M | 175.37M | 147.48M | 181.35M | 209.43M | 151.86M | 116.06M | 107.22M | 67.35M | 104.19M | 84.46M | 112.50M | 100.59M |
| Operating Income Ratio | 37.47% | 32.09% | 32.68% | 31.29% | 30.56% | 36.36% | 38.76% | 37.49% | 35.25% | 31.00% | 19.17% | 17.22% | 16.78% | 16.28% | 14.03% | 12.25% | 11.65% | 8.54% | 14.20% | 14.44% | 22.89% | 30.68% |
| Total Other Income/Expenses | -17.33M | -5.87M | 42.38M | -4.54M | 7.38M | 32.72M | 23.68M | 24.27M | 29.96M | 15.92M | 13.60M | -2.84M | -33.72M | -549.00K | -395.00K | -343.00K | 4.32M | 1.98M | 1.76M | 1.96M | -78.00K | 6.00K |
| Income Before Tax | 414.06M | 438.41M | 439.32M | 331.30M | 314.09M | 377.78M | 365.70M | 333.30M | 377.19M | 258.89M | 188.97M | 144.64M | 179.19M | 208.88M | 151.46M | 115.72M | 111.54M | 69.33M | 105.95M | 86.41M | 112.42M | 100.60M |
| Income Before Tax Ratio | 35.97% | 34.31% | 37.71% | 32.34% | 33.06% | 39.81% | 41.44% | 40.43% | 38.29% | 33.03% | 20.65% | 16.89% | 16.58% | 16.23% | 14.00% | 12.21% | 12.12% | 8.79% | 14.43% | 14.78% | 22.88% | 30.68% |
| Income Tax Expense | 91.39M | 82.56M | 85.16M | 66.50M | 58.74M | 73.82M | 72.73M | 67.38M | 74.99M | 53.75M | 35.87M | 30.14M | 32.88M | 42.04M | 33.12M | 13.59M | 10.38M | 3.45M | 245.00K | 6.23M | 4.00M | 473.00K |
| Net Income | 326.00M | 358.06M | 358.18M | 268.13M | 255.43M | 303.96M | 292.98M | 265.92M | 302.20M | 205.15M | 153.10M | 114.51M | 146.31M | 166.84M | 118.39M | 102.04M | 101.16M | 65.88M | 105.70M | 80.17M | 108.02M | 100.12M |
| Net Income Ratio | 28.32% | 28.02% | 30.74% | 26.18% | 26.89% | 32.03% | 33.20% | 32.26% | 30.68% | 26.17% | 16.73% | 13.37% | 13.53% | 12.97% | 10.94% | 10.77% | 11.00% | 8.35% | 14.40% | 13.71% | 21.98% | 30.53% |
| EPS | 0.22 | 0.24 | 0.24 | 0.17 | 0.16 | 0.19 | 0.18 | 0.17 | 0.19 | 0.13 | 0.10 | 0.07 | 0.09 | 0.11 | 0.08 | 0.06 | 0.06 | 0.04 | 0.07 | 0.05 | 0.08 | 0.08 |
| EPS Diluted | 0.22 | 0.24 | 0.24 | 0.17 | 0.16 | 0.19 | 0.18 | 0.17 | 0.19 | 0.13 | 0.10 | 0.07 | 0.09 | 0.10 | 0.08 | 0.06 | 0.06 | 0.04 | 0.07 | 0.05 | 0.08 | 0.08 |
| Weighted Avg Shares Out | 1.50B | 1.50B | 1.50B | 1.54B | 1.58B | 1.59B | 1.59B | 1.60B | 1.61B | 1.61B | 1.60B | 1.60B | 1.60B | 1.59B | 1.56B | 1.58B | 1.60B | 1.60B | 1.60B | 1.60B | 1.39B | 1.20B |
| Weighted Avg Shares Out (Dil) | 1.50B | 1.50B | 1.51B | 1.55B | 1.58B | 1.59B | 1.59B | 1.61B | 1.61B | 1.62B | 1.60B | 1.60B | 1.60B | 1.59B | 1.57B | 1.59B | 1.61B | 1.61B | 1.60B | 1.60B | 1.39B | 1.20B |
Source: https://incomestatements.info
Category: Stock Reports